TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -4 | -4 | -17 | -26 | -66 | -20 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/08 17:30 | 3/10/08 | GXDX | Genoptix Inc | Health | Health | Medical Laboratories | Waltz Thomas A | CA | D | S | -17 | 25.50 | 0 | -1 | -3 | 19 | I | ||||||||||||||||
3/6/08 17:26 | 3/5/08 | GXDX | Genoptix Inc | Health | Health | Medical Laboratories | Waltz Thomas A | CA | D | S | -102 | 25.50 | 0 | -4 | -17 | 19 | I | ||||||||||||||||
11/5/07 21:00 | 11/2/07 | GXDX | Genoptix Inc | Health | Health | Medical Laboratories | Waltz Thomas A | CA | D | S.d | -40 | 17.00 | 0 | -2 | -9 | 23 | I | ||||||||||||||||
12/22/06 13:00 | 12/22/06 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Waltz Thomas A | CA | D | P.d | 3 | 1.20 | 0 | 3 | New | 3 | I | 4 | 34 | -29 | -8 | -6 | -1 | -3 | -2 | -1 | -4 | -4 | -17 | -26 | -66 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |